S'abonner

Somatic reversion in dedicator of cytokinesis 8 immunodeficiency modulates disease phenotype - 29/05/14

Doi : 10.1016/j.jaci.2014.03.025 
Huie Jing, PhD a, Qian Zhang, MD a, Yu Zhang, PhD a, Brenna J. Hill, PhD b, Christopher G. Dove, BS a, Erwin W. Gelfand, MD c, T. Prescott Atkinson, MD, PhD d, Gulbu Uzel, MD e, Helen F. Matthews, RN f, Peter J. Mustillo, MD g, David B. Lewis, MD h, Fotini D. Kavadas, MD i, I. Celine Hanson, MD j, Ashish R. Kumar, MD, PhD k, Raif S. Geha, MD l, Daniel C. Douek, MD, PhD b, Steven M. Holland, MD e, Alexandra F. Freeman, MD e, Helen C. Su, MD, PhD a,
a Laboratory of Host Defenses, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Md 
e Laboratory of Clinical Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Md 
f Laboratory of Immunology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Md 
b Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Md 
c Division of Allergy and Immunology, Department of Pediatrics, Division of Cell Biology, National Jewish Health, Denver, Colo 
d Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Ala 
g Division of Infectious Diseases and Immunology, Nationwide Children's Hospital, Columbus, Ohio 
h Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, Stanford University, Stanford, Calif 
i Section of Clinical Immunology and Allergy, Department of Pediatrics, Alberta Children's Hospital and University of Calgary, Calgary, Alberta, Canada 
j Section of Allergy and Immunology, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, Tex 
k Cancer and Blood Diseases Institute, Division of Bone Marrow Transplantation and Immune Deficiency and Department of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio 
l Division of Immunology and Department of Pediatrics, Children's Hospital and Harvard Medical School, Boston, Mass 

Corresponding author: Helen C. Su, MD, PhD, Laboratory of Host Defenses, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bldg 10CRC, Rm 5W3940, 10CRC Center Dr, MSC 1456, Bethesda, MD 20892-1456.

Abstract

Background

Autosomal recessive loss-of-function mutations in dedicator of cytokinesis 8 (DOCK8) cause a combined immunodeficiency characterized by atopy, recurrent infections, and cancer susceptibility. A genotype-phenotype explanation for the variable disease expression is lacking.

Objective

We investigated whether reversions contributed to the variable disease expression.

Methods

Patients followed at the National Institutes of Health's Clinical Center were studied. We performed detailed genetic analyses and intracellular flow cytometry to detect DOCK8 protein expression within lymphocyte subsets.

Results

We identified 17 of 34 DOCK8-deficient patients who had germline mutations with variable degrees of reversion caused by somatic repair. Somatic repair of the DOCK8 mutations resulted from second-site mutation, original-site mutation, gene conversion, and intragenic crossover. Higher degrees of reversion were associated with recombination-mediated repair. DOCK8 expression was restored primarily within antigen-experienced T cells or natural killer cells but less so in naive T or B cells. Several patients exhibited multiple different repair events. Patients who had reversions were older and had less severe allergic disease, although infection susceptibility persisted. No patients were cured without hematopoietic cell transplantation.

Conclusions

In patients with DOCK8 deficiency, only certain combinations of germline mutations supported secondary somatic repair. Those patients had an ameliorated disease course with longer survival but still had fatal complications or required hematopoietic cell transplantation. These observations support the concept that some DOCK8-immunodeficient patients have mutable mosaic genomes that can modulate disease phenotype over time.

Le texte complet de cet article est disponible en PDF.

Key words : Dedicator of cytokinesis 8, reversion, somatic repair, recombination, gene conversion, intragenic single crossover, T cell, natural killer cell, allergy, immunodeficiency

Abbreviations used : DOCK8, HCT, NK, SNP, TCR


Plan


 Supported by the Intramural Research Program and the Vaccine Research Center of the National Institutes of Health, National Institute of Allergy and Infectious Diseases.
 Disclosure of potential conflict of interest: T. P. Atkinson has received consultancy fees from the American Board of Allergy & Immunology; has received consultancy fees from Best Doctors; and has received research support from the Kaul Pediatric Research Institute, Children's of Alabama, and the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID). A. R. Kumar has received research support from the NIH/National Heart, Lung, and Blood Institute. R. S. Geha has received research support from the NIAID (1R01AI100315-01A1). The rest of the authors declare that they have no relevant conflicts of interest.


© 2014  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 133 - N° 6

P. 1667-1675 - juin 2014 Retour au numéro
Article précédent Article précédent
  • Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiency
  • Amel Hassan, Pamela Lee, Paraskevi Maggina, Jin Hua Xu, Diana Moreira, Mary Slatter, Zohreh Nademi, Austen Worth, Stuart Adams, Alison Jones, Catherine Cale, Zoe Allwood, Kanchan Rao, Robert Chiesa, Persis Amrolia, Hubert Gaspar, E. Graham Davies, Paul Veys, Andrew Gennery, Waseem Qasim
| Article suivant Article suivant
  • CXCR4/IgG-expressing plasma cells are associated with human gastrointestinal tissue inflammation
  • Clarisa M. Buckner, Susan Moir, Lela Kardava, Jason Ho, Brian H. Santich, Leo Jin Young Kim, Emily K. Funk, Amy K. Nelson, Britanny Winckler, Cheryl L. Chairez, Narda L. Theobald-Whiting, Sandra Anaya-O’Brien, Meghna Alimchandani, Martha M. Quezado, Michael D. Yao, Joseph A. Kovacs, Tae-Wook Chun, Anthony S. Fauci, Harry L. Malech, Suk See De Ravin

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.